- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Abrotinib is an oral JAK1 inhibitor primarily used for the treatment of moderate to severe atopic dermatitis. Long term use requires an evaluat...
Attention should be paid to infection risk monitoring, specific population contraindications, and drug interaction management when using Abroti...
The medication precautions for Ritlecitinib should pay attention to the monitoring of risks and adverse reactions in special populations. Drug ...
Ritlecitinib can be used for a long time in the treatment of alopecia areata, but its efficacy and safety need to be evaluated regularly. Its ...
Ritlecitinib is a novel kinase inhibitor primarily used for the treatment of autoimmune diseases such as alopecia areata. The following provide...
The medication of Ritlecitinib for special populations needs to be personalized according to pregnancy, lactation, reproductive potential, ch...
The use of Olaparib in special populations needs to be adjusted according to pregnancy, lactation, liver and kidney function, and other conditi...
Olaparib, as a PARP inhibitor, exerts anti-tumor effects by blocking the DNA repair pathway. Its drug interactions mainly involve CYP enzyme me...
Asciminib, as a novel kinase inhibitor targeting BCR-ABL1 protein, requires individualized medication plans based on physiological status and o...
The use of Asciminib should pay attention to the management of missed doses, monitoring of adverse reactions, and dietary taboos. The precautio...
